EarLens Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 141
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $33.2M
Latest Deal Amount
  • Investors
  • 22

EarLens General Information

Description

Developer of a contact hearing technology device intended to change the current standard of care for sound performance. The company's device utilizes low-frequency radio and a small lens placed on eardrums to directly activate the natural hearing system and automatically adjusts to challenging listening environments with natural sound and minimal feedback, enabling hearing impaired patients to hear clearly while minimizing the potential for feedback.

Contact Information

Website
www.earlens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 4045-A Campbell Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

EarLens Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EarLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 07-Jan-2021 $33.2M 00000 000.00 Completed Generating Revenue
7. Debt - PPP 28-Apr-2020 00.000 00000 Completed Generating Revenue
6. Later Stage VC 07-Apr-2020 000.00 00000 Completed Generating Revenue
5. Secondary Transaction - Private 06-Apr-2020 00000 Completed Generating Revenue
4. Later Stage VC 22-Oct-2018 0000 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 05-Jun-2017 00000 00000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 11-Apr-2014 $39.8M $44.4M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 03-May-2010 $4.61M $4.61M 000.00 Completed Generating Revenue
To view EarLens’s complete valuation and funding history, request access »

EarLens Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 282,424,648 $0.001000 $0 $0.04 $0.04 1x $0.04 6.21%
To view EarLens’s complete cap table history, request access »

EarLens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a contact hearing technology device intended to change the current standard of care for sound performance.
Therapeutic Devices
Menlo Park, CA
141 As of 2021
00000
00.00 0000-00-00
00000000000 00000

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
00000000000 0000000
Somerset, NJ

00 00000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
00000000000 0000000
Lynge, Denmark
00000 As of 0000
00.000
0&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EarLens Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oticon Corporation Somerset, NJ
00 000000000 Private Equity-Backed Lynge, Denmark 00000 00.000 0&0
00000 Private Equity-Backed Lynge, Denmark 0000 000000000000
0000000 0000000 00 Private Debt Financed Eden Prairie, MN 0000 0000
0000000-000 Private Equity-Backed Minneapolis, MN 000000000 -
You’re viewing 5 of 5 competitors. Get the full list »

EarLens Executive Team (21)

Name Title Board Seat Contact Info
William Facteau Chief Executive Officer, President & Board Member
J. Connon Samuel Chief Operating Officer
Thomas Prescott Chairman
Rodney Perkins MD Founder, Chief Medical Officer & Board Member
You’re viewing 4 of 21 executive team members. Get the full list »

EarLens Board Members (21)

Name Representing Role Since
David Hardie EarLens Board Member 000 0000
Greg Garfield JD KCK Group Board Member 000 0000
Hank Plain Self Board Member 000 0000
Michael Favet KCK Group Board Member 000 0000
Nael Kassar KCK Group Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

EarLens Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EarLens Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARCH Healthcare Fund Venture Capital Minority 000 0000 000000 0
Baltisches Haus Limited Other Minority 000 0000 000000 0
CRG Partners Corporation Minority 000 0000 000000 0
EXOR Seeds Venture Capital Minority 000 0000 000000 0
Far East Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »